- Tel: 858.663.9055
-
Email: info@nsjbio.com
- Tel: 858.663.9055
- Email: info@nsjbio.com
Related Products
|
LONP1 antibody recognizes Lon protease 1, mitochondrial, a highly conserved ATP-dependent protease essential for mitochondrial protein quality control. Encoded by the LONP1 gene on chromosome 19p13.3, this enzyme is located in the mitochondrial matrix and functions as both a chaperone and a protease. It maintains mitochondrial health by degrading misfolded, oxidized, or damaged proteins and by regulating the abundance of metabolic enzymes, mitochondrial transcription factors, and components of oxidative phosphorylation. LONP1 is expressed in nearly all tissues, with particularly high levels in heart, liver, skeletal muscle, and brain, reflecting its importance in energy-demanding environments. Within mitochondria, it co-localizes with matrix-resident metabolic enzymes, mtDNA transcription machinery, and stress-responsive protein networks.
Lon protease 1 plays central roles in mitochondrial proteostasis, stress adaptation, and metabolic regulation. Through ATP-dependent unfolding and degradation mechanisms, LONP1 prevents accumulation of dysfunctional proteins that can impair respiration or lead to mitochondrial fragmentation. It regulates levels of TFAM, the mitochondrial transcription factor required for mtDNA maintenance, thereby influencing mitochondrial biogenesis and genome stability. LONP1 additionally modulates key enzymes of the tricarboxylic acid cycle, fatty acid metabolism, and reactive oxygen species detoxification. Its activity increases during conditions such as hypoxia, oxidative stress, nutrient limitation, and mitochondrial unfolded protein responses.
Alterations in LONP1 expression or activity are associated with several human disorders. Pathogenic variants cause CODAS syndrome, a developmental disorder characterized by cerebral, ocular, dental, auricular, and skeletal abnormalities, likely resulting from impaired mitochondrial proteostasis during embryogenesis. Reduced LONP1 function has been linked to neurodegenerative conditions, age-related mitochondrial decline, and metabolic syndromes driven by impaired oxidative stress handling. Conversely, LONP1 is frequently upregulated in cancers including breast, ovarian, lung, and colorectal tumors, where enhanced mitochondrial protease activity supports high metabolic demand, promotes resistance to oxidative injury, and contributes to tumor cell survival.
At the structural level, LONP1 forms hexameric complexes that encapsulate substrate proteins within a proteolytic chamber. Substrate recognition involves an N-terminal domain, while ATP-driven conformational changes in the AAA+ domain enable unfolding and translocation of proteins into the catalytic core. Isoform variation and regulation by phosphorylation or redox state may influence substrate specificity and enzymatic activity. During development, LONP1 expression increases alongside maturation of mitochondrial networks in energy-intensive tissues and remains dynamically regulated throughout life in response to metabolic and oxidative challenges.
This LONP1 antibody is suitable for detecting Lon protease 1, mitochondrial in research focused on mitochondrial biology, protein quality control, oxidative stress responses, neurodegeneration, cancer metabolism, and developmental studies involving mitochondrial maturation. It supports investigations into mitochondrial proteostasis, biogenesis, and metabolic adaptation under stress. NSJ Bioreagents provides this reagent within its mitochondrial and metabolism-focused antibody collection.
Optimal dilution of the LONP1 antibody should be determined by the researcher.
Amino acids R137-A320 from the human protein were used as the immunogen for the LONP1 antibody.
After reconstitution, the LONP1 antibody can be stored for up to one month at 4oC. For long-term, aliquot and store at -20oC. Avoid repeated freezing and thawing.
Your bulk quote request has been submitted successfully!
Please contact us if you have any questions.